InflaRx Financial Statements From 2010 to 2025
| IFRX Stock | USD 1.23 0.05 4.24% |
Check InflaRx NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InflaRx NV's main balance sheet or income statement drivers, such as , as well as many indicators such as . InflaRx financial statements analysis is a perfect complement when working with InflaRx NV Valuation or Volatility modules.
InflaRx |
InflaRx NV Company Operating Margin Analysis
InflaRx NV's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current InflaRx NV Operating Margin | (124.05) % |
Most of InflaRx NV's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InflaRx NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, InflaRx NV has an Operating Margin of -124.0524%. This is 253.63% higher than that of the Biotechnology sector and 10.69% higher than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
InflaRx NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining InflaRx NV's current stock value. Our valuation model uses many indicators to compare InflaRx NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InflaRx NV competition to find correlations between indicators driving InflaRx NV's intrinsic value. More Info.InflaRx NV is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the InflaRx NV's earnings, one of the primary drivers of an investment's value.About InflaRx NV Financial Statements
InflaRx NV investors use historical fundamental indicators, such as InflaRx NV's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in InflaRx NV. Please read more on our technical analysis and fundamental analysis pages.
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany. Fireman BV is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.